The Adjutor Group is a leading healthcare services company operating globally.
No matter what your stage of product development or lifecycle, we can provide an experienced, tailored team to support your business objectives.
Development, Regulatory & Commercialisation Services

Regulatory Affairs and Market Access
Adjutor are experts in regulatory affairs and market access, able to guide you to market efficiently and effectively.

Sponsorship and Commercialisation
We can help you to access a wide variety of countries and ensure effective commercialisation and product launch strategies.

Quality and Training
We provide QMS system design & implementation that is fit for your purposes, training of staff in the QMS together with a variety of auditing solutions.

Strategy and Project Management
Strategy is key to everything we do. We will design a focused plan of how to achieve your commercial product vision.

Drug and Device Development
We are specialists in drug and device development requirements, including lab, non-clinical and clinical, as well as acting as a CRO.
Clinical Development Services

Clinical Trial Services
Adjutor Clinical provides comprehensive clinical trial services for medicines, medical devices and cell and gene therapies.

Clinical Trial Preparation
All aspects of clinical trial preparation, from planning and protocol development to securing permits & ensuring regulatory readiness.

Clinical Trial Operations
Our clinical team ensure your studies run smoothly from start to finish. We manage site setup, monitoring, logistics, and compliance.
Risk Management
RMP development, writing and review of technical protocols and reports.
Registration Pathways
Orbis / ACCESS / Orphan / Provisional / Priority and other expedited pathways.
QMS System Design
Comprehensive audits covering GMP / GLP / GCP / GDP / ISO9001 / ISO13485.
Data Analytics
Understanding and managing your data and biostatistics.
Why Choose Us?
We get SMEs and the Adjutor Advantage is how we demonstrate, every day, that we are a great partner for your business. We’re engaged, and motivated, to help you at each stage of your journey to market and beyond.
Learn More About Us
We’re a company of down to earth, like-minded, individuals who are enthusiastic and engaged, with a love of life and learning. We work in a collegial way to support each other and our clients.
★★★★★
Excellent quality, timeliness and responsiveness. Polite and helpful. Really felt like one team.
EU Based Biopharmaceutical Company
★★★★★
Our partnership and collaboration with the Adjutor Healthcare team has been phenomenal and has contributed to our successes in Australia, Singapore, and South Korea.
USA Based Biopharmaceutical Company
★★★★★
The consultants are “very knowledgeable, proactive collaborative and excellent communicators.
USA Based Biopharmaceutical Company
★★★★★
My experience over the last couple of years has been very positive and I can’t think of any areas of improvement.
USA Based Biopharmaceutical Company
★★★★★
Very collaborative teams who asked intelligent questions and thought ahead.
EU Based Biopharmaceutical Company
★★★★★
The consultants I work with at Adjutor are “just amazing, responding very quickly, very organised, highly knowledge” … with projects “delivered on time and with high quality standards.
USA Based Biopharmaceutical Company
Latest Insights
Insights • Articles • Latest News • Regulatory Announcements
Stay up to date with industry developments in Australia/New Zealand and beyond.

Regulatory Strategy for Drug and Device Development
Regulatory Strategy for Drug and Device Development. Why it must start on Day One. In the fast-paced world of life sciences innovation, the drive to “get moving” can be irresistible. Teams dive into development, eager to demonstrate progress.Yet the companies that succeed long-term are those that pause first to plan, align, and build a regulatory…

China Drug Regulation Updates 2026
China Drug Regulation Updates 2026 – Strategic Implications for International Biopharma and MedTech China has recently updated the implementing regulations under its Drug Administration Law. The changes reflect a continued shift toward encouraging pharmaceutical innovation while strengthening regulatory oversight across the full product lifecycle. On January 27, 2026, the State Council promulgated the revised “Regulations for the…

2025 A Year in Review
As we approach the close of 2025, it’s essential to reflect on our achievements, growth, and the incredible progress we’ve made together. This year has been transformative, marked by milestones that position The Adjutor Group for even greater success in 2026. As we look forward, we remain committed to innovation, collaboration, and delivering exceptional value…
Ready for growth?
Contact us today and let’s work together to achieve your goals. Whether you have a question, need more information, or want to discuss your project, our team is here to help.







